Docteur, j'ai...

J'ai la diarrhée

Vers questions essentielles

Les diarrhées durent depuis plus de 3 jours ?

1Herikstad H, Yang S, Van Gilder TJ, Yang S, Vugia D, Hadler J, Blake P, Deneen V, Shiferaw B, Angulo FJ. A population-based estimate of the burden of diarrhoeal illness in the United States : FoodNet, 1996-7. Epidemiol Infect 2002 ; 129 : 9-17.

2Gill CJ, Lau J, Gorbach SL, Hamer DH. Diagnostic accuracy of stool assays for inflammatory bacterial gastroenteritis in developed and resource-poor countries. Clin Inf Dis 2003 ; 37 : 365-75.

3Blacklow NR, and Greenberg HB. Viral gastroenteritis. N Eng J Med 1991 ; 325 : 252-64.

4DuPont HL and The Practice Parameters Committee of the American College of Gastroenterology. Guidelines on Acute Infectious Diarrhea in Adults. Am J Gastroenterol 1997 ; 92 : 1962-75.

5Thielman NM, Guerrant RL. Acute infectious diarrhea. N Eng J Med 2004 ; 350 : 38-47.

6Guerrant RL, Van Gilder T, Steiner TS. Practice guidelines for the management of infectious diarrhea (IDSA guidelines). CID 2001 ; 32 : 331-51.

7Diarrhoeal Diseases Study Group : Loperamide in acute diarrhoea in childhood : Results of a double blind, placebo controlled multicenter clinical trial. Br Med J 1984 ; 289 : 1263-7.

8Johnson PC, Ericsson CD, DuPont HL, Morgan DR, Bitsura JAM, Wood LV. Comparison of loperamide with bismuth subsalicylate for the treatment of acute traveler’s diarrhea. JAMA 1986 ; 255 : 757-60.

9Chitkara YK, McCasland KA, Kenefic L. Development and implementation of cost-effective guidelines in the laboratory investigation of diarrhea in a community hospital. Arch Intern Med 1996 ; 156 : 1445-8.

10Dryden MS, Gabb RJE, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis 1996 ; 22 : 1019-25.

11Wiström J, Jertborn M, Ekwall E, Norlin K, Söderquist B, Strömberg A, Lundholm R, Hogevik H, Lagergren L, Englund G, Norrby R and the Swedish Study Group. Empiric treatment of acute diarrheal disease with norfloxacin. Ann Intern Med 1992 ; 117 : 202-8.

12DuPont HL, Ericsson CD, Mathewson JJ, DuPont MW. Five versus three days of ofloxacin therapy for traveler’s diarrhea : A placebo-controlled study. Antimicrob Agents Chemother. 1992 ; 36 : 87-91.

13 Gilbert DN, Moellering RC, Jr, Eliopoulos GM, Sande MA. The Sanford Guide to Antimicrobial Therapy 2006, 36e édition.

14Vila J, Gascon J, Abdalla S, Gomez J, Marco F, Moreno A, Corachan M, Jimenez de Anta T. Antimicrobial resistance of Shigella isolated causing traveler’s diarrhea. Antimicrob Agents Chemother 1994 ; 38 : 2668-70.

15Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis 1998 ; 26 : 341-5.

16Aysev AD, Guriz H. Drug resistance of schigella strains isolated in Ankara, Turkey, 1993-1996. Scan J Infect Dis 1998 ; 30 : 351-3.

17Kuschner RA, Trofa AF, Thomas RJ, Hoge CW, Pitarangsi C, Amato S, Olafson RP, Echeverria P, Sadoff JC, Taylor DN. Use of azithromycin for the treatment of Campylobacter Enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995 ; 21 : 536-41.

18 Delarive J, Oneta C, Kaufmann D. Diarrhées Infectieuses. Acquisitions thérapeutiques 1999 : gastroentérologie. Med Hyg 2000 ; 58 : 241-5.

19Thomson RB, Jr, Haas RA, Thompson JH. Intestinal Parasites : The necessity of examining multiple stool specimens. Mayo Clin Proc 1984 ; 59 : 641-2.

20Hiatt RA, Markell EK, Ng E. How many stool examinations are necessary to detect pathogenic intestinal protozoa ? Am J trop Med Hyg 1995 ; 53 : 36-9.

21 Chappuis F, Loutan L. Parasitoses intestinales : lesquelles et comment les traiter ? Med Hyg 1997 ; 55 : 986-91.

22Juckett G. Intestinal Protozoa. Am Fam Physician 1996 ; 53 : 2507-18.

23 Keusch GT, Hamer D, Joe A, Kelley M, Griffiths J, Ward H. Cryptosporidia – Who is at risk ? Schweiz Med Wochenschr 1995 ; 125 : 899-908.

24Bartlett JG. Antibiotic – Associated Diarrhea. Clin Infect Dis 1992 ; 15 : 573-81.

25Kyne L, Merry C, O’Connel B, Keane C, O’Neill D. Community-acquired Clostridium difficile infection. J Infect 1998 ; 36 : 287-8.

26Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994 ; 330 : 257-62.

27Manabe YC, Vinetz JM, Moore RD, Merz C, Charach P, Bartlett JG. Clostridium difficile colitis : An efficient clinical approach to diagnosis. Ann Intern Med 1995 ; 123 : 835-40.

28Wenisch C, Parschalk B, Hasenhündl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fisidic acid for the treatment of Clostridium difficile – associated diarrhea. Clin Infect Dis 1996 ; 22 : 813-8.

29Buydens P, Debeuckelaere S. Efficacy of SF 68 in the treatment of acute diarrhea. A placebo-controlled trial. Scand J Gastroenterol 1996 ; 31 : 887-91.

30Lewis SJ, Potts LF, Barry RE. The Lack of Therapeutic Effect of Saccharomyces boulardii in the Prevention of Antibiotic-related Diarrhoea in Elderly Patients. J Infect 1998 ; 36 : 171-4.

31Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhea : A meta-analysis of masked, randomized, placebo-controlled trials. Lancet Infect Dis 2006 ; 6 : 374-82.

32McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL. Prevention of B-lactam-associated diarrhea by saccharomyces Boulardii compared with placebo. Am J Gastroenterol 1995 ; 90 : 439-48.

33Koutsou GA, Storey DM, Lee A, Zumbe A, Flourie B, leBot Y, Olivier Ph. Dose-related gastrointestinal response to the ingestion of either isomalt, lactitol or maltitol in milk chocolate. Eur J Clin Nutr. 1996 ; 50 : 17-21.

34Jain NK, Rosenberg DB, Ulahannan MJ, Glasser MJ, Pitchumoni CS. Sorbitol intolerance in adults. Am J Gastroenterol. 1985 ;80 : 678-81.

35Abraham RR, Davis M, Yudkin J, Williams R. Controlled clinical trial of a new non-calorigenic sweetening agent. J Hum Nutr 1981 ; 35 : 165-72.

36Koppel C. Clinical symptomatology and management of mushroom poisoning. Toxicon 1993 ; 31 : 1513-40.

37DuPont HL. Travellers’ diarrhea : Contemporary approaches to therapy and prevention. Drugs 2006 ; 66 : 303-14.

38 Hirschel B, Kaiser L. Le SIDA guide du praticien. 3e édition 1998. Editions Médecine & Hygiène.

39 Laughon BE, Druckman DA, Vernon A, Quinn TC, Polk BF, Modlin JF, Yolken RH, Bartlett JG. Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 1988 ; 94 : 984-93.

40DuPont HL, Marshall GD. HIVVIH-associated diarrhoea and wasting. Lancet 1995 ; 346 : 352-6.

41Quinn TC, Stamm WE, Goodell SE, Mkrtichian E, Benedetti J, Corey L, Schuffler MD, Holmes KK. The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med 1983 ; 309 : 576-82.

42Guerrant RL, Shields DS, Thorson SM, Schorling JB, Groschel DH. Evaluation and diagnosis of acute infectious diarrhea. Am J Med 1985 ; 78 : 91-8.

43Wexner SD. Sexually transmitted diseases of the colon, rectum, and anus. The challenge of the nineties. Dis Colon Rectum 1990 ; 33 : 1048-62.

44Andrews H, Wyke J, Lane M, Clay J, Keighley MR, Allan RN. Prevalence of sexually transmitted disease among male patients presenting with proctitis. Gut 1988 ; 29 : 332-5.

45Surawicz CM, Goodell SE, Quinn TC, Roberts PL, Corey L, Holmes KK, Schuffler MD, Stamm WE. Spectrum of rectal biopsy abnormalities in homosexual men with intestinal symptoms. Gastroenterology 1986 ; 91 : 651-9.

46Quinn TC, Corey L, Chaffee RG, Schuffler MD, Brancato FP, Holmes KK. The etiology of anorectal infections in homosexual men. Am J Med 1981 ; 71 : 395-406.

47Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157 : H7 and the hemolytic-uremic syndrome. N Engl J Med 1995 ; 333 : 364-8.

48Crane JK. Preformed Bacterial Toxins. Clin Lab Med 1999 ; 19 : 583-99.

49Kazal HL. Laboratory diagnosis of foodborne diseases. Ann Clin Lab Sci 1976 ; 6 : 381-99 (V).

50Powell JL. Vibrio species. Clin Lab Med 1999 ; 19 : 537-52.

51Pollack CV Jr, Fuller J. Update on emerging infections from the centers for disease control and prevention. Outbreak of vibrio parahaemolyticus infection associated with eating raw oysters and clams harvested from Long Island Sound-Connecticut, New Jersey, and New York, 1998. Ann Emerg Med 1999 ; 34 : 679-80.

52Easton L. Escherichia coli O157 : occurrence, transmission and laboratory detection. Br J Biomed Sci 1997 ; 54 : 57-64.

53Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, Griffin PM. Escherichia coli O157 : H7 diarrhea in the United States : Clinical and epidemiologic features. Ann Intern Med 1997 ; 126 : 505-13.

54Dryden MS, Keyworth N, Gabb R, Stein K. Asymptomatic foodhandlers as the source of nosocomial salmonellosis. J Hosp Infect. 1994 ; 28 : 195-208.

55 Zwahlen A, Rossier P, Urfer E, Mean F, Krending MJ, Burnens A, Bille J, Francioli P. Fluoroquinolone therapy of acute Salmonella C braenderup gastroenteritis failed to shorten enteric carriage. Abstract J 126, 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, USA, October 1994.